GlobeNewswire Inc | Nov 11, 2020 07:00AM EST

November 11, 2020

NEW YORK, Nov. 11, 2020 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc.(Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases with significant unmet needs, today announced that its Chief Executive Officer, Jesse Shefferman, will present at the Jefferies Virtual London Healthcare Conference on Wednesday, November 18, 2020 at 1:45pm ET.

A webcast of the presentation can be accessed by visiting the Events and Presentations section of the Companys website: https://ir.protaratx.com. The webcast will be archived on the Companys website for 90 days following the presentation.

AboutProtaraTherapeutics, Inc.

Protara is committed to identifying and advancing transformative therapies for people with cancer and rare diseases with limited treatment options. Protaras portfolio includes its lead program, TARA-002, an investigational cell-based therapy being developed for the treatment of non-muscle invasive bladder cancer and lymphatic malformations, and IV Choline Chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure-associated liver disease. For more information, visitwww.protaratx.com.

Company Contact:

Blaine DavisProtara TherapeuticsBlaine.Davis@protaratx.com646-844-0337